Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Catalyst Pharma bags rights to commercialise new class of GABA inhibitors
Catalyst Pharma bags rights to commercialise new class of GABA inhibitors
Catalyst Pharma bags rights to commercialise new class of GABA inhibitors
Submitted by
admin
on September 2, 2009 - 10:06am
Source:
Pharmabiz
News Tags:
GABA inhibitors
Catalyst
Headline:
Catalyst Pharma bags rights to commercialise new class of GABA inhibitors
Do Not Allow Advertisers to Use My Personal information
